Enantioselective aspects of drug action and disposition: therapeutic pitfalls.
暂无分享,去创建一个
[1] D. J. Squires,et al. Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets , 1988, Biopharmaceutics & drug disposition.
[2] F. Jamali,et al. Application of a stereospecific high-performance liquid chromatography assay to a pharmacokinetic study of etodolac enantiomers in humans. , 1988, Journal of pharmaceutical sciences.
[3] P. Carrupt,et al. Influence of Lipophilicity and Chirality on the Selectivity of Ligands for β1‐ and β2‐Adrenoceptors , 1988 .
[4] J. Gal. Stereoisomerism and drug nomenclature , 1988, Clinical pharmacology and therapeutics.
[5] A. Russell,et al. Stereoselective pharmacokinetics of flurbiprofen in humans and rats. , 1988, Journal of pharmaceutical sciences.
[6] J. Lima. Species-dependent binding of disopyramide enantiomers. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[7] F. Jamali,et al. Stereoselective pharmacokinetics of ketoprofen in the rat. Influence of route of administration. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[8] Y. W. Lam,et al. Stereoselectivity: An Issue of Significant Importance in Clinical Pharmacology , 1988, Pharmacotherapy.
[9] R. Dahlqvist,et al. Inhibition of desipramine 2‐hydroxylation by quinidine and quinine , 1988, Clinical pharmacology and therapeutics.
[10] C Y Quon,et al. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. , 1988, Drug metabolism and disposition: the biological fate of chemicals.
[11] I. Tamai,et al. Stereospecific Absorption and Degradation of Cephalexin , 1988, The Journal of pharmacy and pharmacology.
[12] R. Day,et al. Stereoselective disposition of ibuprofen enantiomers in synovial fluid , 1988, Clinical pharmacology and therapeutics.
[13] M. Kraml,et al. The pharmacokinetics of etodolac in serum and synovial fluid of patients with arthritis , 1988, Clinical pharmacology and therapeutics.
[14] B. Testa,et al. Metabolic chiral inversion of anti-inflammatory 2-arylpropionates: lack of reaction in liver homogenates, and study of methine proton acidity. , 1988, Xenobiotica; the fate of foreign compounds in biological systems.
[15] R. Blouin,et al. Age‐associated stereoselective alterations in hexobarbital metabolism , 1988, Clinical pharmacology and therapeutics.
[16] L. Bertilsson,et al. Enantioselectivity of 4-hydroxylation in extensive and poor metabolizers of debrisoquine. , 1988, British journal of clinical pharmacology.
[17] J. Caldwell,et al. Racemates: towards a new year resolution? , 1988 .
[18] S. Toon,et al. The racemic metoprolol H2‐antagonist interaction , 1988, Clinical pharmacology and therapeutics.
[19] F. Jamali,et al. Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. , 1988, Journal of pharmaceutical sciences.
[20] P. Crooks,et al. N‐Methylation of nicotine enantiomers by human liver cytosol , 1988, The Journal of pharmacy and pharmacology.
[21] T. Walle,et al. Stereoselective delivery and actions of beta receptor antagonists. , 1988, Biochemical pharmacology.
[22] D. Drayer. Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in man. , 1988, Therapeutic drug monitoring.
[23] F. Jamali,et al. Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. , 1988, Journal of pharmaceutical sciences.
[24] E. J. Ariëns,et al. Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology. , 1988, Biochemical pharmacology.
[25] J. Caldwell,et al. The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. , 1988, Biochemical pharmacology.
[26] M. Eichelbaum,et al. Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man. , 1988, Biochemical pharmacology.
[27] J. Lima. Interaction of disopyramide enantiomers for sites on plasma protein. , 1987, Life sciences.
[28] C. Fenselau,et al. Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen, and benoxaprofen. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[29] R. Royer,et al. Total and free ketoprofen in serum and synovial fluid after intramuscular injection , 1987, Clinical pharmacology and therapeutics.
[30] A. Breckenridge,et al. The disposition of primaquine in the isolated perfused rat liver. Stereoselective formation of the carboxylic acid metabolite. , 1987, Biochemical pharmacology.
[31] D E Drayer. On the use of drugs administered as racemates , 1987, Clinical pharmacology and therapeutics.
[32] E. J. Ariëns. Implications of the Neglect of Stereochemistry in Pharmacokinetics and Clinical Pharmacology , 1987, Drug intelligence & clinical pharmacy.
[33] E. J. Ariëns,et al. Bias in pharmacokinetics and clinical pharmacology , 1987, Clinical pharmacology and therapeutics.
[34] G. Mulder,et al. Stereoselective glutathione conjugation and amidase-catalyzed hydrolysis of alpha-bromoisovalerylurea enantiomers in isolated rat hepatocytes. , 1987, The Journal of pharmacology and experimental therapeutics.
[35] B. Rauch,et al. Verapamil interaction with the muscarinic receptor: stereoselectivity at two sites. , 1987, Biochemical pharmacology.
[36] W. Trager,et al. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans , 1987, Clinical pharmacology and therapeutics.
[37] H. Thijssen,et al. The biliary excretion of acenocoumarol in the rat: stereochemical aspects , 1987, The Journal of pharmacy and pharmacology.
[38] S. Matlin,et al. Comparative anti-fertility effects of gossypol enantiomers in male hamsters. , 1987, International journal of andrology.
[39] H. Jørgensen,et al. Antinociceptive effects of (±)‐, (+)‐ and (‐)‐nefopam in mice , 1987, The Journal of pharmacy and pharmacology.
[40] Y. Nakamura,et al. Stereoselective metabolism of 2-phenylpropionic acid in rat. II. Studies on the organs responsible for the optical isomerization of 2-phenylpropionic acid in rat in vivo. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[41] E. Ariëns. Stereochemistry in the analysis of drug‐action. Part II , 1987, Medicinal research reviews.
[42] S. Garattini,et al. From Fenfluramine Racemate to d‐Fenfluramine , 1987 .
[43] Lei Hai-Peng,et al. Effect of (+/-)-, (+)- and (-)-gossypol on the lactate dehydrogenase-X activity of rat testis. , 1987 .
[44] D. Drayer,et al. Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits. , 1987, The Journal of pharmacology and experimental therapeutics.
[45] R. Shanks,et al. Clinical Pharmacokinetics of β-Adrenoceptor Antagonists , 1987 .
[46] H. Boudoulas,et al. Stereoselective Effects of Disopyramide Enantiomers in Humans , 1987, Journal of cardiovascular pharmacology.
[47] E. Paulus,et al. Resolution, absolute stereochemistry, and enantioselective activity of nomifensine and hexahydro-1H-indeno[1,2-b]pyridines. , 1987, Journal of medicinal chemistry.
[48] I. Roots,et al. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans. , 1987, The Journal of pharmacology and experimental therapeutics.
[49] G. Breese,et al. Pharmacology of the enantiomers of threo-methylphenidate. , 1987, The Journal of pharmacology and experimental therapeutics.
[50] Y. Tokuma,et al. Determination of (+)- and (-)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry, and a preliminary pharmacokinetic study in humans. , 1987, Journal of pharmaceutical sciences.
[51] R. Mehvar,et al. Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies. , 1987, Drug metabolism and disposition: the biological fate of chemicals.
[52] P. Meffin,et al. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition. , 1987, The Journal of pharmacology and experimental therapeutics.
[53] I. Hayakawa,et al. Inhibition of DNA gyrase by optically active ofloxacin , 1987, Antimicrobial Agents and Chemotherapy.
[54] M. Go,et al. Stereospecific inhibition of cholinesterases by mefloquine enantiomers. , 1987, Chemical & pharmaceutical bulletin.
[55] R. Ruffolo,et al. Interaction of Dopamine, (±)-Dobutamine and the (−)-Enantiomer of Dobutamine with α- and β-Adrenoceptors in the Pulmonary Circulation of the Dog , 1987 .
[56] F. Jamali,et al. High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine. , 1987, Journal of chromatography.
[57] C. Rosini,et al. Chiral stationary phases and circular dichroism detection in high-performance liquid chromatography: Determination of stereochemical purity of drugs. , 1987, Journal of pharmaceutical and biomedical analysis.
[58] M. Eichelbaum,et al. High-performance liquid chromatographic method for the analysis of debrisoquine and its S-(+)- and R-(-)-hydroxy metabolites in urine. , 1987, Journal of chromatography.
[59] R. Day,et al. Clinical pharmacology of non-steroidal anti-inflammatory drugs. , 1987, Pharmacology & therapeutics.
[60] Ö. Ericsson,et al. Enantioselective Analysis of Chloroquine and Desethylchloroquine after Oral Administration of Racemic Chloroquine , 1986, Therapeutic drug monitoring.
[61] A. Breckenridge,et al. Enantiomers of warfarin and vitamin K1 metabolism. , 1986, British journal of clinical pharmacology.
[62] J. Caldwell,et al. The metabolic chiral inversion of 2-phenylpropionic acid in rat, mouse and rabbit. , 1986, Biochemical pharmacology.
[63] D. Notterman,et al. Stereoselective renal tubular secretion of quinidine and quinine , 1986, Clinical pharmacology and therapeutics.
[64] E. Ariëns. Stereochemistry: A source of problems in medicinal chemistry , 1986, Medicinal research reviews.
[65] S. Matlin,et al. Cytotoxicity of enantiomers of gossypol. , 1986, British Journal of Cancer.
[66] M. Curtis,et al. The mechanism of action of the optical enantiomers of verapamil against ischaemia‐induced arrhythmias in the conscious rat , 1986, British journal of pharmacology.
[67] D. Drayer. Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview , 1986, Clinical pharmacology and therapeutics.
[68] B. Bourgeois,et al. Pharmacokinetics of R‐Enantiomeric Normephenytoin During Chronic Administration in Epileptic Patients , 1986, Epilepsia.
[69] H. Jackson,et al. Characterization of the effects of (±)‐meptazinol, its individual enantiomers and N‐methyl meptazinol on food consumption in the rat , 1986, British journal of pharmacology.
[70] D. Ofori-Adjei,et al. [In vitro activity of chloroquine, two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum]. , 1986, Ji sheng chong xue yu ji sheng chong bing za zhi = Journal of parasitology & parasitic diseases.
[71] A. Koster,et al. Stereoselective formation of fenoterol-para-glucuronide and fenoterol-meta-glucuronide in rat hepatocytes and enterocytes. , 1986, Biochemical pharmacology.
[72] R. Branch,et al. Polymorphic metabolism of mephenytoin in man: Pharmacokinetic interaction with a co‐regulated substrate, mephobarbital , 1986, Clinical pharmacology and therapeutics.
[73] N. Singh,et al. Pharmacokinetics of the enantiomers of tiaprofenic acid in humans. , 1986, Journal of pharmaceutical sciences.
[74] J. Turgeon,et al. Stereoselective disposition of mexiletine in man. , 1986, British journal of clinical pharmacology.
[75] D. Parke,et al. Stereoselective pharmacokinetics of perhexiline. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.
[76] P. Kalix. The releasing effect of the isomers of the alkaloid cathinone at central and peripheral catecholamine storage sites , 1986, Neuropharmacology.
[77] A. Duffield,et al. Stereoselective accumulation of hydroxylated metabolites of amphetamine in rat striatum and hypothalamus , 1986, British journal of pharmacology.
[78] C Skoda,et al. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.
[79] R. Isaksson,et al. The enantiomers of the dihydropyridine derivative H 160/51 show opposite effects of stimulation and inhibition. , 1986, European journal of pharmacology.
[80] K. Midha,et al. Chiral pharmacology and its consequences for therapeutic monitoring. , 1986, Clinical biochemistry.
[81] Á. Guzmán,et al. Absolute configuration of (-)-5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-alpha]pyrrole-1-carboxylic acid, the active enantiomer of ketorolac. , 1986, Journal of medicinal chemistry.
[82] M. Terai,et al. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133). , 1986, The Journal of pharmacology and experimental therapeutics.
[83] U. Ruegg,et al. Stereoselectivity at the Calcium Channel: Different Profiles of Hemodynamic Activity of the Enantiomers of the Dihydropyridine Derivative PN 200-110 , 1986, Journal of cardiovascular pharmacology.
[84] Donald F. Smith. The stereoselectivity of serotonin uptake in brain tissue and blood platelets: The topography of the serotonin uptake area , 1986, Neuroscience & Biobehavioral Reviews.
[85] A. Breckenridge,et al. Stereoselective interaction between the R enantiomer of warfarin and cimetidine. , 1986, British journal of clinical pharmacology.
[86] C. Saller,et al. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions. , 1986, European journal of pharmacology.
[87] J. R. Schmid,et al. Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers. , 1986, Journal of medicinal chemistry.
[88] R. Fuller,et al. Fluoxetine enantiomers as antagonists of p-chloroamphetamine effects in rats , 1986, Pharmacology Biochemistry and Behavior.
[89] S. Garattini,et al. d- and l-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. , 1986, European journal of pharmacology.
[90] W. Colburn,et al. Verapamil Pharmacodynamics After Intravenous and Oral Dosing: Theoretic Consideration , 1986, Journal of clinical pharmacology.
[91] I. Hayakawa,et al. Synthesis and antibacterial activities of optically active ofloxacin , 1986, Antimicrobial Agents and Chemotherapy.
[92] P. Lehmann. Stereoisomerism and drug action , 1986 .
[93] T. Walle,et al. Pharmacokinetic parameters obtained with racemates , 1986 .
[94] B. Testa. Chiral aspects of drug metabolism , 1986 .
[95] E. J. Ariëns. Chirality in bioactive agents and its pitfalls , 1986 .
[96] T. Takenaka,et al. Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent, and the corresponding desoxy derivative (YM-11133) in rats. , 1986, Japanese journal of pharmacology.
[97] H. Schmitt,et al. Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects. , 1986, Clinical and experimental hypertension. Part A, Theory and practice.
[98] N. Singh,et al. Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine. , 1986, Journal of chromatography.
[99] H. Smuts,et al. Two isotachophoretically separated components in human cerebrospinal fluid identified as folic acid and uric acid. , 1986, Journal of chromatography.
[100] D. Parke,et al. Further studies on the pharmacokinetics of perhexiline maleate in humans. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.
[101] Robinson Jb. Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors: Enantiomers of amphetamine, n-methylamphetamine and deprenyl , 1985 .
[102] R. Ruffolo,et al. Effects of dopamine, (+/-)-dobutamine and the (+)- and (-)-enantiomers of dobutamine on cardiac function in pithed rats. , 1985, The Journal of pharmacology and experimental therapeutics.
[103] J. Naulty,et al. Differential effects of ketamine stereoisomers on maze performance in the mouse. , 1985, Anesthesiology.
[104] D. A. Lathrop,et al. Electromechanical characterization of the effects of racemic sotalol and its optical isomers on isolated canine ventricular trabecular muscles and Purkinje strands. , 1985, Canadian journal of physiology and pharmacology.
[105] S. Bjorkman. Stereoselective disposition of indoprofen in surgical patients. , 1985 .
[106] P. Taggart,et al. d-Sotalol: a new potent class III anti-arrhythmic agent. , 1985, Clinical science.
[107] G. D. Johnston,et al. A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers. , 1985, British journal of clinical pharmacology.
[108] S. Hjorth,et al. (−)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis , 1985, Neuropharmacology.
[109] R. Ruffolo,et al. Inotropic selectivity of dobutamine enantiomers in the pithed rat. , 1985, The Journal of pharmacology and experimental therapeutics.
[110] K. Giacomini,et al. Stereoselective renal clearance of pindolol in humans. , 1985, The Journal of clinical investigation.
[111] P. Soubrié,et al. Comparison of clenbuterol enantiomers using four psychopharmacological tests sensitive to beta-agonists. , 1985, European journal of pharmacology.
[112] R. Branch,et al. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation , 1985, Clinical pharmacology and therapeutics.
[113] H. Thijssen,et al. Stereoselective aspects in the pharmacokinetics and pharmacodynamics of acenocoumarol and its amino and acetamido derivatives in the rat. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[114] Y. Nakamura,et al. Stereoselective disposition of hydratropic acid in rat. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[115] H. Boudoulas,et al. Stereoselective pharmacokinetics of disopyramide enantiomers in man. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[116] R. Branch,et al. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects. , 1985, The Journal of pharmacology and experimental therapeutics.
[117] M. Bechem,et al. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. , 1985, European journal of pharmacology.
[118] R. B. Carter,et al. Effects of picenadol (LY150720) and its stereoisomers on electric shock titration in the squirrel monkey. , 1985, The Journal of pharmacology and experimental therapeutics.
[119] P. Simon,et al. Psychopharmacological effects of nomifensine enantiomers. , 1985, European journal of pharmacology.
[120] M. Eichelbaum,et al. Effects of d,l‐verapamil on atrioventricular conduction in relation to its stereoselective first‐pass metabolism , 1985, Clinical pharmacology and therapeutics.
[121] T. Walle. Stereochemistry of the in vivo disposition and metabolism of propranolol in dog and man using deuterium-labeled pseudoracemates. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[122] W. L. Nelson,et al. The Pharmacokinetics and Pharmacodynamics of d- and dl-Verapamil in Rabbits , 1985, Journal of cardiovascular pharmacology.
[123] R. Pinder. Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect? , 1985, Acta psychiatrica Scandinavica. Supplementum.
[124] H. Glossmann,et al. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart , 1985, British journal of pharmacology.
[125] H. Haas,et al. Stereoselectivity of l-baclofen in hippocampal slices of the rat , 1985, Neuroscience Letters.
[126] J. W. Cox,et al. Ibuprofen stereoisomer hepatic clearance and distribution in normal and fatty in situ perfused rat liver. , 1985, The Journal of pharmacology and experimental therapeutics.
[127] R. Ruffolo,et al. Systemic hemodynamic effects of dopamine, (+/-)-dobutamine and the (+)-and (-)-enantiomers of dobutamine in anesthetized normotensive rats. , 1985, European journal of pharmacology.
[128] S. Honma,et al. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man. , 1985, Chemical & pharmaceutical bulletin.
[129] S. Matlin,et al. (-)-Gossypol: an active male antifertility agent. , 1985, Contraception.
[130] M. Eichelbaum,et al. The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans. , 1985, American heart journal.
[131] J Schüttler,et al. Comparative pharmacology of the ketamine isomers. Studies in volunteers. , 1985, British journal of anaesthesia.
[132] R. Wolen,et al. Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans. , 1985, Journal of pharmaceutical sciences.
[133] G. Yost,et al. Stereoselective glucuronidation as a probe of induced forms of UDP-glucuronyltransferase in rabbits. , 1985, Drug metabolism and disposition: the biological fate of chemicals.
[134] G. Wilkinson,et al. Mephenytoin hydroxylation deficiency in Caucasians: Frequency of a new oxidative drug metabolism polymorphism , 1984, Clinical pharmacology and therapeutics.
[135] M. Eichelbaum,et al. Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique. , 1984, British journal of clinical pharmacology.
[136] B. Lucchesi,et al. Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. , 1984, Journal of cardiovascular pharmacology.
[137] W. Trager,et al. Pharmacokinetic implications of stereoselective changes in plasma-protein binding: warfarin/sulfinpyrazone. , 1984, Journal of pharmaceutical sciences.
[138] A Yacobi,et al. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats. , 1984, The Journal of pharmacology and experimental therapeutics.
[139] A. Yacobi,et al. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats. , 1984, The Journal of pharmacology and experimental therapeutics.
[140] G. Wahlström,et al. A comparative investigation in the rat of the anesthetic effects of the isomers of two barbiturates , 1984, Brain Research.
[141] M. Contin,et al. Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma. , 1984, British journal of clinical pharmacology.
[142] I. Hughes,et al. Pharmacological effects of meptazinol and its enantiomers on guinea‐pig ileum and mouse vas deferens , 1984, The Journal of pharmacy and pharmacology.
[143] R. Duman,et al. GABAB receptors and norepinephrine-stimulated cAMP production in rat brain cortex , 1984, Brain Research.
[144] M. Simonyi. On chiral drug action , 1984, Medicinal research reviews.
[145] R. Branch,et al. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans. , 1984, The Journal of pharmacology and experimental therapeutics.
[146] G. Giebisch,et al. Effects of enantiomers of indacrinone (MK-196) on cation transport by the loop of Henle and distal tubule studied by microperfusion in vivo. , 1984, The Journal of pharmacology and experimental therapeutics.
[147] M. Eichelbaum,et al. Pharmacokinetics of (+)-, (-)- and (+/-)-verapamil after intravenous administration. , 1984, British journal of clinical pharmacology.
[148] U. Schacht,et al. Stereoselective inhibition of synaptosomal catecholamine uptake by nomifensine. , 1984, European journal of pharmacology.
[149] D. Evans,et al. Polymorphic hydroxylation of perhexiline maleate in man. , 1984, Journal of medical genetics.
[150] W. Kalow,et al. Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. , 1984, Life sciences.
[151] A. Bassindale. The third dimension in organic chemistry , 1984 .
[152] Donald F. Smith. CRC handbook of stereoisomers : drugs in psychopharmacology , 1984 .
[153] F. B. Nicolis,et al. Pharmacokinetics of the enantiomers of indoprofen in man. , 1984, International journal of clinical pharmacology research.
[154] T. Walle,et al. Stereoselective binding of propranolol to human plasma, α1‐acid glycoprotein, and albumin , 1983 .
[155] G. Tucker,et al. Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers , 1983, Clinical pharmacology and therapeutics.
[156] J. Caldwell,et al. The metabolic chiral inversion of 2‐arylpropionic acids—a novel route with pharmacological consequences , 1983, The Journal of pharmacy and pharmacology.
[157] P. Simkin,et al. Antirheumatic Drug Concentrations in Human Synovial Fluid and Synovial Tissue Observations on Extravascular Pharmacokinetics , 1983, Clinical pharmacokinetics.
[158] K. Selvig,et al. Optical resolution, absolute configuration, and activity of the enantiomers of proxyphylline. , 1983, Journal of medicinal chemistry.
[159] D. Yang,et al. Effect of ketamine enantiomers on sound-induced convulsions in epilepsy prone rats. , 1983, Pharmacological research communications.
[160] P. Timmermans,et al. Differential inhibition of α2‐adrenoceptor‐mediated pressor responses by (+)‐ and (‐)‐verapamil in pithed rats , 1983, The Journal of pharmacy and pharmacology.
[161] T. Walle,et al. Stereoselective binding of the (-)-enantiomer of propranolol to plasma and extravascular binding sites in the dog. , 1983, Drug Metabolism And Disposition.
[162] J. Wagner,et al. Pharmacokinetics of ibuprofen in man. I. Free and total area/dose relationships , 1983, Clinical pharmacology and therapeutics.
[163] B. Meldrum,et al. Anticonvulsant action in mice with sound-induced seizures of the optical isomers of γ-vinyl GABA , 1983 .
[164] R. Pinder,et al. The potential therapeutic role of the enantiomers and metabolites of mianserin. , 1983, British journal of clinical pharmacology.
[165] G. Skuza,et al. (+)‐Oxaprotiline but not (‐)‐oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidine , 1983, The Journal of pharmacy and pharmacology.
[166] K. Coulthard,et al. The role of naloxone infusions in the treatment of overdoses of long half-life narcotic agonists: application to nor-methadone. , 1983, British journal of clinical pharmacology.
[167] G. Fromm,et al. Effect of baclofen enantiomorphs on the spinal trigeminal nucleus and steric similarities of carbamazepine. , 1983, Pharmacology.
[168] R. P. Maickel,et al. Differential activity of enantiomers of amphetamine in rats , 1982, Neuropharmacology.
[169] E. Pritchett,et al. Comparison of intravenous and oral verapamil dosing , 1982, Clinical pharmacology and therapeutics.
[170] D. Smith,et al. Stereoselective effect of tranylcypromine enantiomers on brain serotonin. , 1982, Life sciences.
[171] A. Liu,et al. Species-related differences in the stereoselective glucuronidation of oxazepam. , 1982, Drug Metabolism And Disposition.
[172] J. Henry,et al. Effects of intravenously administered enantiomers of baclofen on functionally identified units in lumbar dorsal horn of the spinal cat , 1982, Neuropharmacology.
[173] E. Sybertz,et al. Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalol. , 1982, Journal of medicinal chemistry.
[174] M. Eichelbaum,et al. Application of Stable Labelled Drugs in Clinical Pharmacokinetic Investigations , 1982, Clinical pharmacokinetics.
[175] G. P. Levy,et al. THE α‐ AND β‐ADRENOCEPTOR BLOCKING POTENCIES OF LABETALOL AND ITS INDIVIDUAL STEREOISOMERS IN ANAESTHETIZED DOGS AND IN ISOLATED TISSUES , 1982 .
[176] K. Drauz,et al. Induction of Asymmetry by Amino Acids , 1982 .
[177] W. L. Nelson,et al. The Cardiac Effects of d‐ and 1‐Disopyramide in Normal Subjects: A Noninvasive Study , 1982, Circulation.
[178] J. Hermansson,et al. Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man. , 1982, British journal of clinical pharmacology.
[179] P. Waldmeier,et al. Oxaprotiline, a noradrenaline uptake inhibitor with an active and an inactive enantiomer. , 1982, Biochemical pharmacology.
[180] Roger L. Williams,et al. Effects of probenecid on ketoprofen kinetics , 1982, Clinical pharmacology and therapeutics.
[181] R. Branch,et al. Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. , 1982, The Journal of pharmacology and experimental therapeutics.
[182] N. Holford,et al. Stereoselective disposition and glucuronidation of propranolol in humans. , 1982, Journal of pharmaceutical sciences.
[183] J. Goto,et al. Separation and determination of naproxen enantiomers in serum by high-performance liquid chromatography , 1982 .
[184] A. Karim,et al. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. , 1982, Drug metabolism and disposition: the biological fate of chemicals.
[185] R. Wurtman,et al. Effect of (+)‐ or (−)‐enantiomers of fenfluramine or norfenfluramine on nutrient selection by rats , 1982, The Journal of pharmacy and pharmacology.
[186] M. Dobrinska,et al. Stereoselectivity in the disposition and metabolism of the uricosuric-diuretic agent, indacrinone, in Rhesus monkeys. , 1982, Drug metabolism and disposition: the biological fate of chemicals.
[187] M. Ames,et al. Stereochemical aspects of para-chloroamphetamine metabolism. Rabbit liver microsomal metabolism of RS-, R(-)-. and S(+)-para-chloroamphetamine. , 1982, Biochemical pharmacology.
[188] M. Eichelbaum. Defective Oxidation of Drugs: Pharmacokinetic and Therapeutic Implications , 1982, Clinical pharmacokinetics.
[189] F. Vane,et al. High-performance liquid chromatographic determination of stereoselective disposition of carprofen in humans. , 1981, Journal of pharmaceutical sciences.
[190] T. Meinertz,et al. Pharmacokinetics of the enantiomers of acenocoumarol in man. , 1981, British journal of clinical pharmacology.
[191] R. Ruffolo,et al. Alpha and beta adrenergic effects of the stereoisomers of dobutamine. , 1981, The Journal of pharmacology and experimental therapeutics.
[192] F. Carroll,et al. Synthesis and pharmacological activity of thiohexital enantiomers. , 1981, Journal of medicinal chemistry.
[193] J. Thompson,et al. Glucuronidation of propranolol and 4'-hydroxypropranolol. Substrate specificity and stereoselectivity of rat liver microsomal glucuronyltransferases. , 1981, Drug metabolism and disposition: the biological fate of chemicals.
[194] S. Garattini,et al. Effect of optical isomers of (±)‐fenfluramine on pentobarbitone brain and plasma concentrations and sleeping time , 1981, The Journal of pharmacy and pharmacology.
[195] C. Sabin,et al. Alpha and beta adrenoceptor blocking properties of labetalol and its R,R-isomer, SCH 19927. , 1981, The Journal of pharmacology and experimental therapeutics.
[196] P. J. Wills,et al. Epimers of moxalactam: in vitro comparison of activity and stability , 1981, Antimicrobial Agents and Chemotherapy.
[197] R. Davies,et al. Pharmacology of enantiomers and (–) p‐OH metabolite of indacrinone , 1981, Clinical pharmacology and therapeutics.
[198] J. C. Bailey,et al. Electrophysiological Effects of the Optical Isomers of Disopyramide and Quinidine in the Dog , 1981, Circulation research.
[199] R. H. Evans,et al. The depressant action of baclofen on the isolated spinal cord of the neonatal rat. , 1981, European journal of pharmacology.
[200] E. Sellers,et al. Methadone binding to orosomucoid (α1‐acid glycoprotein): Determinant of free fraction in plasma , 1981 .
[201] T. Ichihashi,et al. Plasma protein binding and urinary excretion of R- and S-epimers of an arylmalonylamino 1-oxacephem. I: In humans. , 1981, Journal of pharmaceutical sciences.
[202] H. Cheng,et al. Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol. , 1980, Life sciences.
[203] S. Riegelman,et al. Stereospecific assay for (-)- and (+)-propranolol in human and dog plasma. , 1980, The Journal of pharmacology and experimental therapeutics.
[204] K. Giacomini,et al. Comparative anticholinergic potencies of R- and S- disopyramide in longitudinal muscle strips from guinea pig ileum. , 1980, Life sciences.
[205] W. L. Nelson,et al. Resolution, absolute configuration, and antiarrhythmic properties of the enantiomers of disopyramide, 4-(diisopropylamino)-2-(2-pyridyl)-2-phenylbutyramide. , 1980, Journal of medicinal chemistry.
[206] G. Reynolds,et al. Effects of tranylcypromine stereoisomers on monamine oxidation in man. , 1980, British journal of clinical pharmacology.
[207] V. Kliem,et al. Inhibition of an active calcium transport system in cardiac sarcolemma by ouabain involvement of sodium and potassium , 1980 .
[208] P. White,et al. Pharmacology of Ketamine Isomers in Surgical Patients , 1980, Anesthesiology.
[209] M. Arita,et al. Effects of verapamil and its optical isomers on repetitive slow responses induced by electrical depolarization in canine ventricular myocardium. , 1980, Japanese heart journal.
[210] S. Toki,et al. Stereoselective hydroxylation of hexobarbital enantiomers by rat liver microsomes. , 1980, Drug metabolism and disposition: the biological fate of chemicals.
[211] W. Trager,et al. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man. , 1980, The Journal of clinical investigation.
[212] T. Saruta,et al. Mechanism of renin inhibition by beta adrenergic blocking agents. Effects of dl-, d-, l-propranolol and pindolol on renin release. , 1980, Japanese heart journal.
[213] E. R. Shepard,et al. Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans. , 1979, Drug metabolism and disposition: the biological fate of chemicals.
[214] E. Smith,et al. New antiarrhythmic agents. 1. Primary alpha-amino anilides. , 1979, Journal of medicinal chemistry.
[215] B. Meldrum,et al. The anticonvulsant action of the (−)‐ and (+)‐enantiomers of propranolol , 1979, The Journal of pharmacy and pharmacology.
[216] A. Breckenridge,et al. CIMETIDINE: INTERACTION WITH ORAL ANTICOAGULANTS IN MAN , 1979, The Lancet.
[217] W. Stec,et al. Comparative metabolism of 2-[bis(2-chloroethyl)amino]tetrahydro-2-H-1,3,2-oxazaphosphorine-2-oxide (cyclophosphamide) and its enantiomers in humans. , 1979, Cancer research.
[218] G. Zon,et al. Effects of enantiomeric homogeneity on the in vitro metabolism and in vivo anticancer activity of (+)- and (-)-cyclophosphamide. , 1979, Biochemical pharmacology.
[219] S. Sisenwine,et al. Diastereoisomeric glucuronides of oxazepam. Isolation and stereoselective enzymic hydrolysis. , 1979, Drug metabolism and disposition: the biological fate of chemicals.
[220] G. Reynolds,et al. Deprenyl is metabolized to methamphetamine and amphetamine in man. , 1978, British journal of clinical pharmacology.
[221] H. Haas,et al. The biological activity of d-baclofen (Lipresal®) , 1978 .
[222] W. Stec,et al. Stereoselectivity in the metabolism of the enantiomers of cyclophosphamide in mice, rats, and rabbits. , 1978, Drug metabolism and disposition: the biological fate of chemicals.
[223] Toshikiro Kimura,et al. CARRIER-MEDIATED TRANSPORT SYSTEMS FOR AMINOPENICIL-LINS IN RAT SMALL INTESTINE , 1978 .
[224] S. Caccia,et al. Stereoselective disposition of fenfluramine enantiomers in the rat. , 1978, Xenobiotica; the fate of foreign compounds in biological systems.
[225] F. Reynolds,et al. An intradermal study of the local anaesthetic and vascular effects of the isomers of bupivacaine. , 1978, British journal of clinical pharmacology.
[226] E. Cragoe,et al. (Acylaryloxy)acetic acid diuretics. 2. (2-Alkyl-2-aryl-1-oxo-5-indanyloxy)acetic acids. , 1978, Journal of medicinal chemistry.
[227] D. Azarnoff,et al. Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH , 1978, Clinical pharmacology and therapeutics.
[228] E. Schillinger,et al. Stereospecific plasma binding of gliflumide, a new antidiabetic drug. , 1978, Biochemical pharmacology.
[229] J. Michenfelder,et al. Cerebral Protection with Barbiturates Relation to Anesthetic Effect , 1978, Stroke.
[230] A. Cho,et al. Pathways of metabolism of amphetamine and related compounds. , 1978, Life sciences.
[231] L. B. Wingard,et al. Pharmacokinetics of warfarin enantiomers: A search for intrasubject correlations , 1978, Clinical pharmacology and therapeutics.
[232] T. Meinertz,et al. Anticoagulant activity of the enantiomers of acenocoumarol. , 1978, British Journal of Clinical Pharmacology.
[233] N. Castagnoli,et al. Chapter 31. Enantioselectivity in Drug Metabolism , 1978 .
[234] S. Caccia,et al. Differences in the availability of d- and l-enantiomers after administration of racemic amphetamine to rats. , 1978, Xenobiotica; the fate of foreign compounds in biological systems.
[235] J. Bircher,et al. Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog. , 1977, The Journal of pharmacology and experimental therapeutics.
[236] J. Idle,et al. POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.
[237] E. Jähnchen,et al. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats , 1977, The Journal of pharmacy and pharmacology.
[238] W. L. Way,et al. On the pharmacology of the ketamine enantiomorphs in the rat. , 1977, The Journal of pharmacology and experimental therapeutics.
[239] L. H. Schmidt,et al. Comparison of the Curative Antimalarial Activities and Toxicities of Primaquine and Its d and l Isomers , 1977, Antimicrobial Agents and Chemotherapy.
[240] N. Gerber,et al. Clinical eftects and pharmacokinetics of racemic methadone and its optical isomers , 1977, Clinical pharmacology and therapeutics.
[241] B. Koe. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. , 1976, The Journal of pharmacology and experimental therapeutics.
[242] K. Kawashima,et al. Disposition of propranolol isomers in mice. , 1976, European journal of pharmacology.
[243] P. Murphy,et al. Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat. , 1976, The Journal of pharmacology and experimental therapeutics.
[244] L. Czyzewski,et al. Trimethoquinol-different pharmacological properties of optical isomers. , 1976, Biochemical pharmacology.
[245] S. Snyder,et al. Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency , 1976, Nature.
[246] T. Meinertz,et al. The enantiomers of phenprocoumon: Pharmacodynamic and pharmacokinetic studies , 1976, Clinical pharmacology and therapeutics.
[247] T. Leigh,et al. Optical isomers of 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine (viloxazine) and related compounds. , 1976, Journal of medicinal chemistry.
[248] K. Voith,et al. Behavioral studies on the enantiomers of butaclamol demonstrating absolute optical specificity for neuroleptic activity. , 1976, Canadian journal of physiology and pharmacology.
[249] P. Farmer,et al. Observations on the differential metabolism and biological activity of the optical isomers of cyclophosphamide. , 1976, Biochemical pharmacology.
[250] T. Haley,et al. Pharmacological comparison of R(+), S(-) and racemic thiopentone in mice. , 1976, European journal of pharmacology.
[251] W. Wechter,et al. Isomeric inversion of ibuprofen (R)-enantiomer in humans. , 1976, Journal of pharmaceutical sciences.
[252] O. Sjaastad,et al. SHORT‐TERM CLINICAL TRIAL of PROPRANOLOL IN RACEMIC FORM (INDERAL), D‐PROPRANOLOL and PLACEBO IN MIGRAINE , 1976, Acta neurologica Scandinavica.
[253] Grant R. Wilkinson,et al. A physiological approach to hepatic drug clearance , 1975 .
[254] R. Mcmahon,et al. The difference in activity between (+)‐ and (‐)‐methadone is intrinsic and not due to a difference in metabolism , 1975, The Journal of pharmacy and pharmacology.
[255] A. Liu,et al. Excretion and stereoselective biotransformations of dl-, d- and l-norgestrel in women. , 1975, Drug metabolism and disposition: the biological fate of chemicals.
[256] U. Wollert,et al. High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate. , 1975, Molecular pharmacology.
[257] W. Wechter,et al. Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-) p-iso-butyl hydratropic acid. , 1974, Biochemical and biophysical research communications.
[258] A. Breckenridge,et al. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man , 1974, Clinical pharmacology and therapeutics.
[259] R. Branch,et al. The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver. , 1973, Drug metabolism and disposition: the biological fate of chemicals.
[260] D. Breimer,et al. Pharmacokinetics of (+)‐, (−)‐ and (±)‐hexobarbitone in man after oral administration , 1973 .
[261] C. Hawkins,et al. Relative Potency of (-)- and (±)-Salbutamol on Guinea Pig Tracheal Tissue , 1973 .
[262] J. Mcewen,et al. Plasma half‐lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man * , 1973, The Journal of pharmacy and pharmacology.
[263] J. B. Farmer,et al. Some observations on the β‐adrenoceptor agonist properties of the isomers of salbutamol , 1973, British journal of pharmacology.
[264] J. Morris,et al. Active Transport of L-Dopa in the Intestine , 1973, Nature.
[265] B. Testa,et al. The influence of stereochemical factors on drug disposition. , 1973, Drug metabolism reviews.
[266] D. Shand,et al. Regional hemodynamic effects of beta-adrenergic blockade with propranolol in the unanesthetized primate. , 1973, American heart journal.
[267] S. Snyder,et al. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine. , 1972, The Journal of pharmacology and experimental therapeutics.
[268] D. Middlemiss,et al. Absolute configuration of the optical isomers of salbutamol. , 1971, Journal of medicinal chemistry.
[269] W. Rummel,et al. Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. , 1970, The Journal of pharmacology and experimental therapeutics.
[270] D. Shand,et al. Plasma Propranolol Levels in the Quantitative Assessment of β-adrenergic Blockade in Man , 1970, British medical journal.
[271] T. Haley,et al. Pharmacological comparison of R(+), S(-) and racemic secobarbital in mice. , 1970, European journal of pharmacology.
[272] W. Forrest,et al. Analgesic and other effects of the d‐ and l‐isomers of pentazocine , 1969, Clinical pharmacology and therapeutics.
[273] G. Hite,et al. The absolute configurations of the pheniramines, methyl phenidates, and pipradrols. , 1969, Journal of medicinal chemistry.
[274] M. G. Evans,et al. The effect of the dextro isomer of propranolol on sinus rate and cardiac arrhythmias. , 1968, American heart journal.
[275] R. Howe,et al. Beta-adrenergic blocking agents. 3. The optical isomers of pronethalol, propranolol, and several related compounds. , 1968, Journal of medicinal chemistry.
[276] A. Barrett,et al. The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias , 1968, British journal of pharmacology.
[277] W. Forrest,et al. Respiratory and subjective effects of d‐ and I‐pentazocine , 1968, Clinical pharmacology and therapeutics.